Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Innovation /
      About the Johnson & Johnson Women in STEM²D Scholars Award Program

      About the Johnson & Johnson Women in STEM²D Scholars Award Program

      Share Article
      share to
      WiSTEM microscope

      The Johnson & Johnson Scholars Award Program aims to fuel the development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their research careers, in each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design.

      The awards will fund one woman per discipline who has completed her advanced degree, who is working as an assistant professor or global equivalent and who is not yet tenured at an accredited university or design institution. The goal is to fuel the research passion of the awarded women and inspire career paths in their respective STEM2D fields.

      By offering these awards, Johnson & Johnson hopes to play an influential role in STEM2D breakthroughs in the future.

      WiSTEM2D Scholars Award

      The Johnson & Johnson WiSTEM²D Scholars Award Program will help develop female leaders and support innovation in STEM fields.

      More from Johnson & Johnson

      Innovation
      Headshots of three Johnson and Johnson female scientists

      Meet 3 leaders who are breaking new ground for women in healthcare

      For International Women’s Day, celebrate the achievements of these amazing female scientists and researchers at Johnson & Johnson.
      Innovation
      Close-up of a woman with low vision receiving an eye exam exam with a doctor shining light into her left eye

      What is low vision?

      Low vision isn’t the same as blindness, but navigating daily life with it is still challenging. For Low Vision Awareness Month, learn the facts—plus, the promising treatment innovations that are in the works.
      Innovation
      A female scientist conducting research in a laboratory, focusing on orphan drugs for rare diseases

      What is an orphan drug?

      The need for these rare disease therapies is strong, and access to them can be lifesaving. Here’s how Johnson & Johnson is innovating to help give patients options.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.